scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicDrug price regulator

Topic: drug price regulator

Govt move to review drug pricing mechanism triggers concern as pharma industry invited to join panel

Panel formed by Centre to review pricing framework for drugs & medical devices will have representatives from Indian Pharmaceutical Alliance & Indian Drug Manufacturers Association.

Are 3 firms selling ibuprofen injectables at inflated MRP? Drug price regulator probes

New Delhi: A panel under the country’s drug pricing agency, the National Pharmaceutical Pricing Authority (NPPA), has flagged that the injectible version of a...

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

Mankind Pharma, Intas found selling diabetes drug ‘without nod’, to get show cause notice

Delhi-based Mankind Pharma & Gujarat's Intas Pharmaceuticals sold a Type 2 diabetes drug without seeking price approval from National Pharmaceutical Pricing Authority.

Paradise Papers: Fortis Chairman under drug price regulator’s scanner for Singapore stents

NPPA takes cognisance of ‘leaked’ documents saying Dr Ashok Seth bought shares from a Singapore company that supplied stents to the hospital chain. 

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.